November 21, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Medtronic In.Pact AV drug-coated balloon ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
Now, more than ever, the field of cardiology needs women.
But as the national need for more cardiologists overall ...
November 21, 2019 — At the American Heart Association Scientific Sessions 2019, Eko, a digital health company applying a ...
November 21, 2019 — People who experience cardiac arrests over the weekend are less likely to survive long enough to be ...
November 21, 2019 — Endotronix, a digital health and medical technology company dedicated to advancing the treatment of ...
It’s an exciting time in the heart failure (HF) world right now with the emergence of new therapies, including ...
November 21, 2019 — Merck announced the results from the Phase 3 VICTORIA Study evaluating the efficacy and safety of ...
November 19, 2019 — Since Maquet/Datascope first recalled all of its intra-aortic balloon pumps (IABP) due to reports ...
November 19, 2019 — Here is a list of the key late-breaking clinical study presentations and links to the results at the ...
November 7, 2019 — The ClotTriever Outcomes (CLOUT) Registry is evaluating real-world patient outcomes following ...
November 14, 2019 — More than a million Americans face a doubling in their risk of death during or while recovering from ...
November 7, 2019 — The IN.PACT Arteriovenous (AV) Access randomized trial evaluating the safety and effectiveness of the ...
November 7, 2019 — The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for ...
November 8, 2019 — Penumbra Inc. announced that the EXTRACT-PE trial successfully met the primary endpoints ...